drug protocol number

NN9924-4542

drug sponsor

Novo Nordisk

drug study

Oral semaglutide (Rybelsus®)

drug trial site

Specialized Medical Center (Riyadh),My Clinic (Jeddah),Dallah Hospital (Riyadh),Dr. Sulaiman Al-Habib Medical Group (Riyadh),Dr. Soliman Fakeeh Hospital (Jeddah),Saudi German Hospital (Jeddah),Almoosa Hospital,Mouwasat Hospital

drug status

Ongoing

drug phase